×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [41]
复旦大学上海医学院 [22]
山东大学 [16]
吉林大学白求恩第一医... [7]
武汉大学 [6]
湖南大学 [5]
更多...
内容类型
期刊论文 [131]
会议论文 [8]
发表日期
2022 [2]
2021 [1]
2020 [3]
2019 [19]
2018 [22]
2017 [32]
更多...
学科主题
Oncology; ... [2]
Oncology [1]
Respirator... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共139条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H
期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:
Guo, Huihui
;
Zhang, Xilin
;
Xie, Shangzhi
;
Chen, Tianwei
;
Xie, Dong
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/22
gefitinib
CD28H
NSCLC
EGFR mutation
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Jin, Ying
;
Lin, Chen
;
Shi, Xun
;
He, Qiong
;
Yan, Junrong
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/12/23
Clinical and molecular features
Efficacy and outcome
EGFR T790M mutation
Non-small-cell lung cancer
Osimertinib
Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2021
作者:
Si, Jinfei
;
Gu, Xiaodong
;
Wang, Wenxian
;
Ying, Shenpeng
;
Song, Zhengbo
收藏
  |  
浏览/下载:60/0
  |  
提交时间:2022/02/14
Epidermal growth factor receptor (EGFR)
uncommon mutation
compound mutation
double uncommon mutation
lung adenocarcinoma (lung AC)
Safety, Clinical Activity, and Pharmacokinetics of Al flutinib (AST2818) in Patients With Advanced NSCLC With EGFR T790M Mutation
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2020, 卷号: 15, 期号: 6, 页码: 1015-1026
作者:
Shi, Yuankai
;
Zhang, Shucai
;
Hu, Xingsheng
;
Feng, Jifeng
;
Ma, Zhiyong
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2020/12/24
Alflutinib
NSCLC
EGFR T790M mutation
Efficacy
Safety
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:
Lin, Chen
;
Shi, Xun
;
Zhao, Jun
;
He, Qiong
;
Fan, Yun
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/10/26
tumor mutation burden (TMB)
clinical benefit
epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)
chemotherapy
non-small cell lung cancer (NSCLC)
BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation
期刊论文
THERANOSTICS, 2020, 卷号: 10, 期号: 14, 页码: 6122-6135
作者:
Yin, Weimin
;
Zhao, Yuge
;
Kang, Xuejia
;
Zhao, Pengfei
;
Zhao, Xuhong
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2020/07/01
brain targeting delivery
tumor-associated macrophage
non-small cell lung cancer (NSCLC)
drug resistance
tyrosine kinase inhibitors (TKI)
EGFR T790M mutation
EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC
期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 卷号: 38, 页码: 15
作者:
Qin, Jianhua
;
Liu, Yang
;
Yin, Yalei
;
Sun, Mingju
;
Zhan, Xi
收藏
  |  
浏览/下载:107/0
  |  
提交时间:2019/06/20
Bromodomain
JQ1
MAPK pathway
MYC
EGFR mutation
Sorafenib
Egfr signaling confers resistance to bet inhibition in hepatocellular carcinoma through stabilizing oncogenic myc
期刊论文
Journal of experimental & clinical cancer research, 2019, 卷号: 38, 页码: 15
作者:
Yin, Yalei
;
Sun, Mingju
;
Zhan, Xi
;
Wu, Changqing
;
Geng, Pengyu
收藏
  |  
浏览/下载:137/0
  |  
提交时间:2019/05/08
Bromodomain
Jq1
Mapk pathway
Myc
Egfr mutation
Sorafenib
Successful treatment of a lung adenocarcinoma patient with a novel EGFR exon 20-ins mutation with afatinib A case report
期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 1
作者:
Cai, Yangyang
;
Wang, Xu
;
Guo, Ye
;
Sun, Chao
;
Xu, Yinghui
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/12/05
afatinib
EGFR exon 20-ins mutation
EGFR-TKI
lung cancer
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China
期刊论文
LUNG CANCER, 2019, 卷号: 127
作者:
Gu, Xiaohua
;
Zhang, Qiang
;
Chu, Yun-Bo
;
Zhao, Yi-Yang
;
Zhang, Yan-Jun
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/12/05
Afatinib
EGFR mutation
Cost-effectiveness
Non-small cell lung cancer
©版权所有 ©2017 CSpace - Powered by
CSpace